News

RMIT University-Led Researchers Develop AI-Powered Glaucoma Screening Test With Rapid Results

KUALA LUMPUR, Oct 28 — A new rapid screening test for glaucoma could help advance early detection of the disease, a leading cause of irreversible blindness.

Developed by a research team of engineers and ophthalmologists led by RMIT University in Melbourne, Australia, the test uses infra-red sensors to monitor eye movement and can produce accurate results within seconds.

According to a statement, about 80 million people worldwide have glaucoma, with more than 111 million expected to be living with the disease by 2040.

Currently, glaucoma is diagnosed through a 30-minute eye pressure test delivered by an ophthalmologist. The new AI-powered test takes just 10 seconds to show if there is a risk of glaucoma, making it ideal for use in a national screening programme.

Lead researcher Professor Dinesh Kumar, RMIT, said early detection, diagnosis and treatment could help prevent blindness, so making screening faster and more accessible was critical.

“This research will allow a non-contact, easy-to-use and low-cost test that can perform routinely at general clinics. It could also promote a community-wide screening programme, reaching people who might not otherwise seek treatment until it’s too late,” he added.

The pioneering technology differentiates between glaucoma and healthy eyes by analysing changes in pupil size. In the study, published in IEEE Access, pupils were measured 60 times per second using a low-cost commercial eye tracker.

Under ambient light conditions, patients looked at a computer screen while custom software measured and analysed specific changes in their pupil size. The software then compared the results against existing samples of glaucoma and healthy eyes to determine the risk of glaucoma.

The team is now looking to adapt the technology to work with smartphone cameras instead of the eye tracker used in the study. They are also looking for a commercial partner ahead of a clinical trial planned for 2022.

With further research, the software could also be extended to detect other neurological conditions.

Sources: BERNAMA

Adib Mohd

Recent Posts

Cisco Secure AI Factory with NVIDIA Makes AI Easier to Deploy and Secure, Anywhere Organizations Need It

Cisco (NASDAQ: CSCO) today announced a major expansion of its Secure AI Factory with NVIDIA,… Read More

57 minutes ago

Take Style Cues from DK, SEUNGKWAN, and DINO with Skechers’ New Hotshot Collection

With SEVENTEEN continuing to shape global pop culture, Skechers taps into its influence to redefine… Read More

21 hours ago

LG Electronics Unveil All-New, iF Award-Winning Indoor Unit Lineup for Water Heating Solutions

LG Electronics is turning up the heat, literally. At Mostra Convegno Expocomfort (MCE) 2026 in… Read More

22 hours ago

Kuala Lumpur Convention Centre Malaysia’s First ISO 20121-Certified Purpose-Built Venue

The Kuala Lumpur Convention Centre (KLCC) just made history. It’s now Malaysia’s first purpose-built venue… Read More

23 hours ago

A Season of Sweet Indulgence this Easter with Marks & Spencer

Marks & Spencer welcomes the Easter season with a deliciously indulgent collection of treats. These… Read More

23 hours ago

Zurich Malaysia and Singapore x Project 1000, Turning Endurance into Empowerment Across Southeast Asia

Building on Zurich’s spirit of collaboration across Asia Pacific, Zurich Malaysia and Zurich Singapore have… Read More

1 day ago

This website uses cookies.